DIVIS LABORATORIES
Back to Cashflow Statement
|
DIVIS LABORATORIES Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹50 Cr | ₹193 Cr | ₹-1,045 Cr | ₹-816 Cr | ₹1,987 Cr |
What is the latest Net Cash Inflow / Outflow ratio of DIVIS LABORATORIES ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2025 | ₹50 Cr |
Mar2024 | ₹193 Cr |
Mar2023 | ₹-1,045 Cr |
Mar2022 | ₹-816 Cr |
Mar2021 | ₹1,987 Cr |
How is Net Cash Inflow / Outflow of DIVIS LABORATORIES Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2025 | ₹50 Cr | -74.09 | |
Mar2024 | ₹193 Cr | Positive | |
Mar2023 | ₹-1,045 Cr | Negative | |
Mar2022 | ₹-816 Cr | Negative | |
Mar2021 | ₹1,987 Cr | - |
Compare Net Cash Inflow / Outflow of peers of DIVIS LABORATORIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
DIVIS LABORATORIES | ₹164,574.2 Cr | 2.4% | 3.2% | 11.9% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹397,342.0 Cr | 3.4% | 1.3% | -11.6% | Stock Analytics | |
CIPLA | ₹127,259.0 Cr | 1.8% | 1.9% | -5.6% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹122,898.0 Cr | 2.8% | -0.9% | 3.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,394.0 Cr | 1.7% | 6.2% | -0.3% | Stock Analytics | |
MANKIND PHARMA | ₹109,835.0 Cr | 3% | 6.2% | 7.5% | Stock Analytics |
DIVIS LABORATORIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
DIVIS LABORATORIES | 2.4% |
3.2% |
11.9% |
SENSEX | 0.9% |
1.2% |
-0.4% |
You may also like the below Video Courses